ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PPII Coenzyme A Inc (CE)

0.0002
0.00 (0.00%)
11 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Coenzyme A Inc (CE) USOTC:PPII OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0002 0.00 00:00:00

Pro-Pointer, Inc. Introduces Revolutionary New Energy Drink, Annual Revenues Could Exceed $50 Million Dollars

23/08/2010 9:00pm

Marketwired


Coenzyme A (CE) (USOTC:PPII)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more Coenzyme A (CE) Charts.

Pro Pointer, Inc. (PINKSHEETS: PPII), through its wholly owned subsidiary Coenzyme-A Technologies, Inc., is pleased to announce its latest innovative proprietary formulation, the COENZYME-A "Body Energizer Drink"™. The formula contains a balanced combination of active nutritional components, cognitive enhancers and cellular energy promoting nutrients, immune system boosters and detoxifying agents, into an appealing and tasty beverage for consumers.

"In contrast to today's sugar and caffeine stimulant drinks that can create a high/low energy cycle, including a spike in the insulin levels of the consumer, the Coenzyme-A 'Body Energizer Drink' is a whole body, mind, and natural mood enhancing energy drink that is not addictive, does not affect the natural sleeping patterns, and has no adverse side effects while maintaining energy levels and preventing hunger and weakness," stated Nickolaos D. Skouras, PhD, President/CEO of Coenzyme-A Technologies, Inc. "We are confident this is the first nutraceutical energy drink to combine nutritional components that can be used by the body to support its manufacture and utilization of Acetyl Coenzyme-A with a specific set of substrates that are designed to assist the body in stabilizing blood sugar levels while increasing energy and alertness," Dr. Skouras added.

The world nutraceutical market, which is expected to top $15 billion this year, has enjoyed double-digit growth over the last few years and is expected to continue. Growth is believed to be driven by new product introductions and health consciousness within the aging populations. The US baby boomers, which are expected to reach 80 million by 2012, drive the US market in the sense that they are the generation which is most likely to demand control over the course of their medical care. Coenzyme-A Technologies, Inc. plans to penetrate this market through new and existing distribution channels as well as the implementation of an aggressive world-wide internet marketing campaign.

The national Energy Beverage Market well exceeds a Billion Dollars annually. A comparable Energy Drink (in price only and not quality) "The 5-Hour Energy drink" reports weekly sales of over four million bottles that translates to gross sales of over $48 Million per month, and $576 Million per year. Given the above current statistics, the Coenzyme-A "Body Energizer Drink"™ when properly advertised and promoted to reach consumer awareness could well exceed $50 Million in annual revenue.

ABOUT COENZYME-A TECHNOLOGIES, INC. -- Coenzyme-A Technologies, Inc. is an innovative company that has applied new technology to the formulation and manufacture of a series of proprietary products which address nutritional deficiencies that result from the stress of modern day living, chemical imbalances within the body, and the deleterious effects of aging. Coenzyme-A is the first nutraceutical product to combine nutritional components that can be successfully used by the body to support its manufacture and utilization of cellular Coenzyme-A (The Master Coenzyme). Coenzyme-A contains a specific set of substrates that are designed to assist the body in converting fats, carbohydrates and proteins into energy at the cellular level. See Company website -- www.coenzyme-a.com.

FORWARD-LOOKING STATEMENTS The information contained in this news release, other than historical information, consists of forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Such forward-looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, market acceptance, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Contact Information: Pro-Pointer, Inc. 458 Coral Sea St. Henderson, Nv. 89074 Ph- 702-458-4111 Cell-702-591-7440

1 Year Coenzyme A (CE) Chart

1 Year Coenzyme A (CE) Chart

1 Month Coenzyme A (CE) Chart

1 Month Coenzyme A (CE) Chart

Your Recent History